Scientists in the Netherlands have discovered microplastics in human blood for the first time from nearly 80 percent of 22 anonymous, healthy volunteers, warning that the ubiquitous particles could also be making their way into organs.
Half of the blood samples showed traces of PET plastic, widely used to make drink bottles, while more than a third had polystyrene, used for disposable food containers and many other products.
The Dutch study was published in the Environment International journal.
The microplastics, tiny pieces of mostly invisible plastic, have already been found almost everywhere from the deepest oceans to the highest mountains as well as in the air, soil, and food chain.
According to Dick Vethaak, an ecotoxicologist at Vrije Universiteit Amsterdam, it was the first time they detected and quantified such microplastics in human blood, which is proof that we have plastics in our body -- and we shouldn't.
He added that further research is needed to investigate how it could impact health by determining where it is going in the body, if it can be eliminated or excreted, or if it is retained in certain organs, or able to pass the blood-brain barrier.
The study said the microplastics could have entered the body via air, water, or food, and in products such as particular lip glosses, toothpaste, and tattoo ink.
Vethaak added that there could be other kinds of microplastics in the blood that his study did not pick up as it could not detect particles larger than the diameter of the needle used to take the sample.
The study was funded by the Netherlands Organisation for Health Research and Development UK-based Common Seas, which aims to reduce plastic pollution.


Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
As the Black Summer megafires neared, people rallied to save wildlife and domestic animals. But it came at a real cost
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
LA fires: Long-term exposure to wildfire smoke is poorly understood − and a growing risk
Fertile land for growing vegetables is at risk — but a scientific discovery could turn the tide
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 



